Phospho-Akt2 (Ser474) antibody | knockout validation | Cell Signaling 8599

This is a knockout-validated antibody summary, based on the publication "AKT isoform-specific expression and activation across cancer lineages", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Phospho-Akt2 (Ser474) antibody | knockout validation | Cell Signaling 8599 figure 1
Figure 1. Western blot of AKT2 and pAKT2 in HCT116 parental, AKT2−/−, and AKT1−/− cells serum starved overnight and treated (or not treated) with insulin (20 μg/ml) for 30 min. ERK immunoblotting showed equivalent loading. From [1].
Antibody information

Rabbit monoclonal IgG

Company: Cell Signaling

Antibody: Phospho-Akt2 (Ser474)

Catalog number: 8599

Summary: Rabbit monoclonal IgG against a synthetic phosphopeptide corresponding to residues surrounding Ser474 of human Akt2 protein. Reacts with human, mouse and rat. Suitable for western blot and immunoprecipitation.

Validation Method

Western blot

Sample

HCT116 parental, AKT2−/−, and AKT1−/− cells. Cells were lysed in radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and 0.1% sodium dodecyl sulfate), supplemented with protease inhibitor and phosphatase inhibitor cocktails (Pierce Biotechnology, Rockford, IL).

References
  1. Wang J, Zhao W, Guo H, Fang Y, Stockman S, Bai S, et al. AKT isoform-specific expression and activation across cancer lineages. BMC Cancer. 2018;18:742 pubmed publisher